TW201737904A - 認知機能改善劑 - Google Patents
認知機能改善劑 Download PDFInfo
- Publication number
- TW201737904A TW201737904A TW106112422A TW106112422A TW201737904A TW 201737904 A TW201737904 A TW 201737904A TW 106112422 A TW106112422 A TW 106112422A TW 106112422 A TW106112422 A TW 106112422A TW 201737904 A TW201737904 A TW 201737904A
- Authority
- TW
- Taiwan
- Prior art keywords
- vitamin
- cognitive function
- present
- zinc
- dementia
- Prior art date
Links
- 230000001149 cognitive effect Effects 0.000 title abstract description 3
- 230000003920 cognitive function Effects 0.000 claims abstract description 56
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 50
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 39
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 38
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 36
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 34
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 34
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 32
- 235000016804 zinc Nutrition 0.000 claims abstract description 25
- 239000011701 zinc Substances 0.000 claims abstract description 25
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 25
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 23
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 21
- 239000011710 vitamin D Substances 0.000 claims abstract description 21
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 20
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 20
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 20
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 20
- 239000011719 vitamin A Substances 0.000 claims abstract description 20
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 20
- 229940045997 vitamin a Drugs 0.000 claims abstract description 20
- 229940046008 vitamin d Drugs 0.000 claims abstract description 20
- 229960002685 biotin Drugs 0.000 claims abstract description 19
- 235000020958 biotin Nutrition 0.000 claims abstract description 19
- 239000011616 biotin Substances 0.000 claims abstract description 19
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229960000304 folic acid Drugs 0.000 claims abstract description 18
- 235000019152 folic acid Nutrition 0.000 claims abstract description 18
- 239000011724 folic acid Substances 0.000 claims abstract description 18
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 18
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 17
- 235000001055 magnesium Nutrition 0.000 claims abstract description 17
- 239000011777 magnesium Substances 0.000 claims abstract description 17
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 17
- 229940091250 magnesium supplement Drugs 0.000 claims abstract description 17
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 17
- 239000011709 vitamin E Substances 0.000 claims abstract description 17
- 229940046009 vitamin E Drugs 0.000 claims abstract description 17
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 16
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 16
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 16
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 16
- 239000011718 vitamin C Substances 0.000 claims abstract description 16
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 16
- 229930003270 Vitamin B Natural products 0.000 claims abstract description 13
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 13
- 239000011720 vitamin B Substances 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 7
- 241000124008 Mammalia Species 0.000 claims abstract description 5
- 239000004615 ingredient Substances 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 abstract description 12
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010012289 Dementia Diseases 0.000 description 29
- 208000010877 cognitive disease Diseases 0.000 description 15
- 208000027061 mild cognitive impairment Diseases 0.000 description 15
- 239000000126 substance Substances 0.000 description 13
- 229930014626 natural product Natural products 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 11
- 235000013305 food Nutrition 0.000 description 9
- 239000000825 pharmaceutical preparation Substances 0.000 description 8
- 229940127557 pharmaceutical product Drugs 0.000 description 8
- -1 retinoyl alcohol Chemical compound 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 208000024827 Alzheimer disease Diseases 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000015067 sauces Nutrition 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 230000002407 ATP formation Effects 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 4
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 4
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 4
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 4
- 239000004129 EU approved improving agent Substances 0.000 description 3
- 235000013734 beta-carotene Nutrition 0.000 description 3
- 239000011648 beta-carotene Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- 229930000083 3-dehydroretinol Natural products 0.000 description 2
- QXNWZXMBUKUYMD-ITUXNECMSA-N 4-keto-beta-carotene Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C QXNWZXMBUKUYMD-ITUXNECMSA-N 0.000 description 2
- 206010003062 Apraxia Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 244000294411 Mirabilis expansa Species 0.000 description 2
- 235000015429 Mirabilis expansa Nutrition 0.000 description 2
- 241000237502 Ostreidae Species 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- XWCYDHJOKKGVHC-UHFFFAOYSA-N Vitamin A2 Chemical compound OCC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C XWCYDHJOKKGVHC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- RZFHLOLGZPDCHJ-DLQZEEBKSA-N alpha-Tocotrienol Natural products Oc1c(C)c(C)c2O[C@@](CC/C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)(C)CCc2c1C RZFHLOLGZPDCHJ-DLQZEEBKSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000002205 anti-dementic effect Effects 0.000 description 2
- 201000007201 aphasia Diseases 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- WGIYGODPCLMGQH-UHFFFAOYSA-N delta-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C WGIYGODPCLMGQH-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 229960003530 donepezil Drugs 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000007941 film coated tablet Substances 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 229960003980 galantamine Drugs 0.000 description 2
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229960004640 memantine Drugs 0.000 description 2
- BUGYDGFZZOZRHP-UHFFFAOYSA-N memantine Chemical compound C1C(C2)CC3(C)CC1(C)CC2(N)C3 BUGYDGFZZOZRHP-UHFFFAOYSA-N 0.000 description 2
- 206010027175 memory impairment Diseases 0.000 description 2
- 235000013536 miso Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 235000020636 oyster Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229960004136 rivastigmine Drugs 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 239000007940 sugar coated tablet Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- FGYKUFVNYVMTAM-UHFFFAOYSA-N (R)-2,5,8-trimethyl-2-(4,8,12-trimethyl-trideca-3t,7t,11-trienyl)-chroman-6-ol Natural products OC1=CC(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-UHFFFAOYSA-N 0.000 description 1
- OTXNTMVVOOBZCV-UHFFFAOYSA-N 2R-gamma-tocotrienol Natural products OC1=C(C)C(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-UHFFFAOYSA-N 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- HRQKOYFGHJYEFS-UHFFFAOYSA-N Beta psi-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C HRQKOYFGHJYEFS-UHFFFAOYSA-N 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- QYMRNXGQXPEGNA-UHFFFAOYSA-N C[Co+].N Chemical compound C[Co+].N QYMRNXGQXPEGNA-UHFFFAOYSA-N 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- 201000011240 Frontotemporal dementia Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 241000519695 Ilex integra Species 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- ZZFBEYCTUIPLDE-UHFFFAOYSA-M O[Co+].N Chemical compound O[Co+].N ZZFBEYCTUIPLDE-UHFFFAOYSA-M 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 201000004810 Vascular dementia Diseases 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- NBZANZVJRKXVBH-ITUXNECMSA-N all-trans-alpha-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CCCC2(C)C)C NBZANZVJRKXVBH-ITUXNECMSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 229940064063 alpha tocotrienol Drugs 0.000 description 1
- IGABZIVJSNQMPZ-UHFFFAOYSA-N alpha-Zeacarotene Natural products CC(C)=CCCC(C)=CCCC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C IGABZIVJSNQMPZ-UHFFFAOYSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- 229940005524 anti-dementia drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- SXFQDYORBVIULR-UHFFFAOYSA-N azane;cobalt(2+) Chemical compound N.[Co+2] SXFQDYORBVIULR-UHFFFAOYSA-N 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- FGYKUFVNYVMTAM-YMCDKREISA-N beta-Tocotrienol Natural products Oc1c(C)c2c(c(C)c1)O[C@@](CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)(C)CC2 FGYKUFVNYVMTAM-YMCDKREISA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- 239000011774 beta-cryptoxanthin Substances 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000005978 brain dysfunction Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229940068682 chewable tablet Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- UCTLRSWJYQTBFZ-DDPQNLDTSA-N cholesta-5,7-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC=C21 UCTLRSWJYQTBFZ-DDPQNLDTSA-N 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 230000003931 cognitive performance Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- WGIYGODPCLMGQH-ZNTKZCHQSA-N delta-Carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C WGIYGODPCLMGQH-ZNTKZCHQSA-N 0.000 description 1
- 235000001581 delta-carotene Nutrition 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000006932 echinenone Nutrition 0.000 description 1
- YXPMCBGFLULSGQ-YHEDCBSUSA-N echinenone Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(=O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C YXPMCBGFLULSGQ-YHEDCBSUSA-N 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000015897 energy drink Nutrition 0.000 description 1
- FGYKUFVNYVMTAM-MUUNZHRXSA-N epsilon-Tocopherol Natural products OC1=CC(C)=C2O[C@@](CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-MUUNZHRXSA-N 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- DNVPQKQSNYMLRS-APGDWVJJSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-APGDWVJJSA-N 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000004503 fine granule Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- OTXNTMVVOOBZCV-YMCDKREISA-N gamma-Tocotrienol Natural products Oc1c(C)c(C)c2O[C@@](CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)(C)CCc2c1 OTXNTMVVOOBZCV-YMCDKREISA-N 0.000 description 1
- 239000011663 gamma-carotene Substances 0.000 description 1
- 235000000633 gamma-carotene Nutrition 0.000 description 1
- HRQKOYFGHJYEFS-RZWPOVEWSA-N gamma-carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=1C(C)(C)CCCC=1C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C HRQKOYFGHJYEFS-RZWPOVEWSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 125000000946 retinyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019685 rice crackers Nutrition 0.000 description 1
- 235000019992 sake Nutrition 0.000 description 1
- 235000014438 salad dressings Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000011270 sweet biscuits Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 102000013498 tau Proteins Human genes 0.000 description 1
- 108010026424 tau Proteins Proteins 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000008256 whipped cream Substances 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 235000008924 yoghurt drink Nutrition 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- OMSYGYSPFZQFFP-UHFFFAOYSA-J zinc pyrophosphate Chemical compound [Zn+2].[Zn+2].[O-]P([O-])(=O)OP([O-])([O-])=O OMSYGYSPFZQFFP-UHFFFAOYSA-J 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- AGFGXVAAIXIOFZ-UHFFFAOYSA-L zinc;butanedioate Chemical compound [Zn+2].[O-]C(=O)CCC([O-])=O AGFGXVAAIXIOFZ-UHFFFAOYSA-L 0.000 description 1
- RZFHLOLGZPDCHJ-XZXLULOTSA-N α-Tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C RZFHLOLGZPDCHJ-XZXLULOTSA-N 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000019145 α-tocotrienol Nutrition 0.000 description 1
- 239000011730 α-tocotrienol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 235000019151 β-tocotrienol Nutrition 0.000 description 1
- 239000011723 β-tocotrienol Substances 0.000 description 1
- FGYKUFVNYVMTAM-WAZJVIJMSA-N β-tocotrienol Chemical compound OC1=CC(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-WAZJVIJMSA-N 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
- 235000019150 γ-tocotrienol Nutrition 0.000 description 1
- 239000011722 γ-tocotrienol Substances 0.000 description 1
- OTXNTMVVOOBZCV-WAZJVIJMSA-N γ-tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-WAZJVIJMSA-N 0.000 description 1
- 239000002446 δ-tocopherol Substances 0.000 description 1
- 235000019144 δ-tocotrienol Nutrition 0.000 description 1
- 150000003790 δ-tocotrienols Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本發明係提供一種以維生素A、維生素B群(B1、B2、B6及B12)、維生素C、維生素D、維生素E、鋅、鎂、泛酸、生物素及葉酸為有效成分的認知機能改善劑,並提供一種改善認知機能的方法,其係包含將維生素A、維生素B群(B1、B2、B6及B12)、維生素C、維生素D、維生素E、鋅、鎂、泛酸、生物素及葉酸投予哺乳動物之步驟。
Description
本發明係關於認知機能改善劑,以及改善認知機能之方法。
在日本,隨著人口的高齡化,失智症的患者日益增加而成為社會的巨大問題。並且,由於失智症的前階段為MCI(Mild Cognitive Impairment,輕度認知障礙),因此被認為存在相當數量的MCI高齡患者。
MCI係處於失智症與健全者之中間階段(灰色地帶)的症狀,為認知機能(記憶、判斷、合理化、實行等)內其中一項產生問題,但不影響日常生活之狀態。若將MCI置之不理,認知機能會持續低落,約有半數將進入失智症之階段。由於目前失智症大部份都無法完全治好,因此在MCI之階段進行適切預防,防止症狀之進展係極為重要。
失智症之種類,主要有阿茲海默型失智症、路易氏體失智症、血管型失智症及額顳葉型失智症此4種。
其中,以阿茲海默症為失智症中最多,佔了老年期之失智症的一半以上。並且,阿茲海默症之特徵,係為從初老期至老年期所發生的進行性之痴呆。現在於日本國內之患者數為300萬人以上。阿茲海默症之臨床症狀,係為記憶障礙、高階腦機能障礙(失用症、失認症、失語症、
結構型失用症等)等。阿茲海默症被認為,其原因係由於腦內β類澱粉蛋白及Tau蛋白之累積,導致神經細胞死亡。
目前,對於失智症係使用4劑之抗失智症藥(多耐派齊(donepezil)、美金剛胺(memantine)、加蘭他敏(galantamine)、及利巴斯狄明(rivastigmine))。一般而言,藉由投予此4劑內之1劑或2劑,可使失智症之進行延遲數年。
為了使腦順利發揮機能,作為能量源之充足ATP(三磷酸腺苷)係為必要,而多數的失智症患者,係此ATP之產生有所下降。ATP之產生係於40歲以後,逐年下降,若以40歲時為百分之100,在80歲時則僅有6成。ATP量的低落係促進了認知機能的低落(亦即失智症容易發病),然而抗失智症之4劑藥,雖增加腦內的乙醯膽鹼,卻無法提升ATP量。進一步地,腦循環‧代謝改善劑由於係促進ATP產生因此可被使用,但其具有現行中只能用於腦梗塞等器官障礙後之缺點。
此外,係已揭露可使用與磷脂醯絲胺酸複合之銀杏抽出物,作為改善失智症及阿茲海默症之食品或醫藥的有效成分(專利文獻1)。另一方面,將維生素B、維生素C、維生素E、β-胡蘿蔔素、葉酸等單獨或複數(約2~3種)組合的補充劑,已被報導對認知機能之改善並不有效。
【專利文獻1】日本專利第5300196號公報
【非專利文獻1】Art S, et al, Neurochem Res 37:2706-2714, 2012
【非專利文獻2】Petersen RC, et al, N Engl J Med 352:2379-2388, 2005
【非專利文獻3】Kang JH, et al, Circulation 119:2772-2780, 2009
【非專利文獻4】Aisen PS, et al, JAMA 300:1774-1783, 2008
【非專利文獻5】van Uffelen JG, et al, Br J Sports Med 42:344-351, 2008
本發明目的在於提供一種具有認知機能之改善效果的認知機能改善劑,及一種改善認知機能之方法。
如前所述,藉由目前抗失智症藥之失智症治療無法呈現充分成果的根本原因,在於無法提升ATP之產生。ATP係經由TCA循環之7階段的反應而產生,而作為各反應之補酶的維生素類係扮演重要角色。亦即,維生素類的充分補充可促進ATP的產生。
本發明人為達成上述目的而重複深入研究的結果,得到可藉由含有維生素A、維生素B群(B1、B2、B6及B12)、維生素C、維生素D、維生素E、鋅、鎂、泛酸、生物素及葉酸之補充劑達成上述目的之見解。
本發明係基於此等見解,進一步重複探討而完成,並提供下述認知機能改善劑者。
第1項:一種認知機能改善劑,其係以維生素A、維生素B群(B1、B2、B6及B12)、維生素C、維生素D、維生素E、鋅、鎂、泛酸、生物素及葉酸作為有效成分。
第2項:如第1項所記載之認知機能改善劑,其中,維生素D之含有量係為0.0008質量%以上。
第3項:如第1或2項所記載之認知機能改善劑,其中,維生素A之含有量係為0.085質量%以下。
第4項:如第1至3項所記載之認知機能改善劑,其中,鋅之含有量係為0.35質量%以下。
第5項:一種在認知機能改善劑(認知機能改善用保健用食品)之製造中,使用維生素A、維生素B群(B1、B2、B6及B12)、維生素C、維生素D、維生素E、鋅、鎂、泛酸、生物素及葉酸的方法。
第6項:一種改善認知機能之方法,其係包含將維生素A、維生素B群(B1、B2、B6及B12)、維生素C、維生素D、維生素E、鋅、鎂、泛酸、生物素及葉酸投予哺乳動物之步驟。
第7項:一種認知機能改善用組成物,其係含有他命A、維生素B群(B1、B2、B6及B12)、維生素C、維生素D、維生素E、鋅、鎂、泛酸、生物素及葉酸。
本發明之認知機能改善劑,係具有MCI及失智症之患者之認知機能的改善效果。
本發明之認知機能改善劑,雖單獨使用之效果亦可期許,惟藉由與抗失智症治療藥之併用,可期許有效地延遲失智症之進行,及認知機能之改善。進一步地,本發明之認知機能改善劑,對維持MCI及失智症患者之ADL(日常生活活動)亦可期許。
以下,係對本發明進行詳細說明。
又,本說明書中的「包含(comprise)」係包含「實質上由...組成(essentially consist of))」之意義及「由...組成(consist of)」之意義。
本發明之認知機能改善劑,其特徵係其以(或包含)維生素A、維生素B群(B1、B2、B6及B12)、維生素C、維生素D、維生素E、鋅、鎂、泛酸、生物素及葉酸為有效成分。
本發明之維生素A,係包含維生素A1(視網醇)、視網醇、視網酸、維生素A2(3-脫氫視網醇)、3-脫氫視網醇、3-脫氫視網酸、此等之誘導體、此等之酯體、原維生素A、此等之鹽等。酯體係可列舉與各種脂肪酸之酯體(維生素A醋酸酯等);原維生素A係可列舉α-胡蘿蔔素、β
-胡蘿蔔素、γ-胡蘿蔔素、δ-胡蘿蔔素、茄紅素、玉米黃素、β-隱黃素、海膽烯酮(echinenone)等。維生素A可單獨1種或組合2種以上而使用。本發明之維生素A,係可使用從天然物分離者及化學合成者中任一種。
本發明之維生素B1,係包含硫胺素及其鹽等。本發明之維生素B1,係可使用從天然物分離者及化學合成者中任一種。
本發明之維生素B2,係包含核黃素及其鹽等。本發明之維生素B2,係可使用從天然物分離者及化學合成者中任一種。
本發明之維生素B6,係包含吡哆醇、吡哆醛、吡哆胺、及此等之鹽等。維生素B6可單獨1種或組合2種以上而使用。本發明之維生素B6,係可使用從天然物分離者及化學合成者中任一種。
本發明之維生素B12,係包含鈷銨、羥鈷銨、腺苷鈷胺、甲基鈷銨、氰鈷銨、亞硫酸鈷胺及此等之鹽等。維生素B12可單獨1種或組合2種以上而使用。本發明之維生素B12,係可使用從天然物分離者及化學合成者中任一種。
本發明之維生素C,係包含抗壞血酸及其鹽等。本發明之維生素C,係可使用從天然物分離者及化學合成者中任一種。
本發明之維生素D(鈣化醇),係包含維生素D2~D7及此等之鹽等。本發明之維生素D,以維生素D2、維生素D3、原維生素D2及原維生素D3為較佳。維生素D可單獨1種或組合2種以上而使用。本發明之維生素D,係可使用從天然物分離者及化學合成者中任一種。
本發明之維生素E,係包含α-生育酚、β-生育酚、γ-生育酚、δ-生育酚、α-生育三烯醇、β-生育三烯醇、γ-生育三烯醇、δ-
生育三烯醇及此等之鹽等。維生素E可單獨1種或組合2種以上而使用。本發明之維生素E,係可使用從天然物分離者及化學合成者中任一種。
本發明之鎂,係包含鎂及其鹽等。鎂鹽係可列舉氧化鎂、氯化鎂、碳酸鎂、硫酸鎂等。鎂可單獨1種或組合2種以上而使用。本發明之鎂,係可使用從天然物分離者及化學合成者中任一種。
本發明之鋅,係包含鋅及其鹽等。鋅之有機酸鹽,係可列舉焦磷酸鋅、檸檬酸鋅、琥珀酸鋅、葡萄糖酸鋅等;鋅之無機酸鹽,係可列舉氯化鋅、硫酸鋅等。鋅可單獨1種或組合2種以上而使用。本發明之鋅,係可使用從天然物分離者及化學合成者中任一種。此外,本發明之鋅,亦可直接使用鋅酵母、牡蠣等含鋅之素材,或使用其經粗精製者。
本發明之泛酸,係包含泛酸及其鹽等。本發明之泛酸,係可使用從天然物分離者及化學合成者中任一種。
本發明之生物素,係包含生物素及其鹽等。本發明之生物素,係可使用從天然物分離者及化學合成者中任一種。此外,本發明之生物素,亦可直接使用含有生物素之酵母等含生物素之素材,或使用其經粗精製者。
本發明之葉酸,係包含葉酸、葉酸之誘導體、此等之鹽等。本發明之葉酸,係可使用從天然物分離者及化學合成者中任一種。
本發明之認知機能改善劑中,維生素A、維生素B群(B1、B2、B6及B12)、維生素C、維生素D、維生素E、鋅、鎂、泛酸、生物素及葉酸之含有量係無特別限制,例如,可以後述之成人每1日之攝取量設定為各有效成分之含有量。
本發明之認知機能改善劑中維生素A之含量,係無特別限定,以0.00001質量%以上為較佳,且0.0001質量%以上為進一步較佳;以0.085質量%以下為較佳,且0.0085質量%以下為進一步較佳。
本發明之認知機能改善劑中維生素D之含量,係無特別限定,以0.0008質量%以上為較佳,且0.0010質量%以上為進一步較佳;以0.0068質量%以下為較佳,且0.0021質量%以下為進一步較佳。
本發明之認知機能改善劑中鋅之含量,係無特別限定,以0.0001質量%以上為較佳,且0.001質量%以上為進一步較佳;以0.35質量%以下為較佳,且0.28質量%以下為進一步較佳。
本發明之認知機能改善劑,其含義亦包含醫藥品、醫藥部外品及飲食品(例如健康食品、營養組成物(nutritional composition)、營養補助食品、機能性食品、營養補助食品、補充劑、保健用食品、特定保健用食品、營養機能食品、機能性表示食品等)。此外,本發明之認知機能改善劑,其含意亦包含賦予認知機能改善作用之添加劑。
上述飲食品,因應需求,除上述之有效成分外,亦可因應需求而配合礦物質類、維生素類、類黃酮類、醌類、多酚類、胺基酸、核酸、必需脂肪酸、酵素、澱粉、食用油脂、甜味劑、酸味劑、苦味劑、調味料、色素、香料、保存劑、漂白劑、加工劑、清涼劑、增黏劑、乳化劑、安定劑、防腐劑、膨脹劑、界面活性劑、結著劑、溶解劑、濕潤劑、賦形劑、
滑潤劑、結合劑、崩解劑、抗氧化劑、pH調整劑、光澤劑、膠基等。
上述飲食品之種類,係包含哺乳動物(包含人)可攝取之所有飲食品,例如,可列舉乳製品;發酵食品(優格、乳酪等);飲料類(咖啡、果汁、可可亞、茶飲料、運動飲料、如能量飲料之清涼飲料、乳飲料、乳酸菌飲料、添加乳酸菌飲料、優格飲料、碳酸飲料、如日本酒、洋酒、果實酒之酒等);抹醬類(卡士達糊等);醬類(水果醬等);西式點心類(巧克力、甜甜圈、派、鮮奶油、口香糖、軟糖、果凍、糖果、甜餅乾、蛋糕、布丁、餅乾等);日式點心類(大福、麻糬、饅頭、卡斯特拉、餡蜜、羊羹、仙貝、米菓、糖等);冰點心(冰淇淋、冰棒、雪酪等);食品類(咖哩、牛丼、雜炊、味噌湯、湯、肉醬、義大利麵、醃漬物、醬、火腿、香腸、培根等);調味料類(沙拉醬、拌飯素、增味劑、湯塊、味噌、醬油、醬汁、番茄醬、蠔油等)等。
作為補充劑等使用時之投藥劑型型態,並無特別限制,可適當選擇適合者。例如,可列舉錠劑(例如裸錠、糖衣錠、膜衣錠、咀嚼錠、口含錠等)、膠囊劑、細粒劑、顆粒劑、液劑、散劑、糖漿、藥膏、飲劑等
上述飲食品之製法並無特別限制,可適宜遵循習知之方法。
本發明之認知機能改善劑之攝取量,可因應攝取者之體重、年齡、性別、症狀等種種條件而適宜設定。對於成人每1日的本發明之認知機能改善劑之各有效成分之攝取量,並無特別限制,例如,可列舉如下述者:維生素A:以50~3,000μg為較佳,進一步較佳為50~300μg。
維生素B1:以25~200mg為較佳,進一步較佳為50~150mg。
維生素B2:以10~100mg為較佳,進一步較佳為20~60mg。
維生素B6:以10~100mg為較佳,進一步較佳為20~60mg。
維生素B12:以100~1,500μg為較佳,進一步較佳為450~1,000μg。
維生素C:以100~5,000mg為較佳,進一步較佳為1,000~3,000mg。
維生素D:以5~250μg為較佳,進一步較佳為10~75μg。
維生素E:以50~800mg為較佳,進一步較佳為67~400mg。
鋅:以2~12mg為較佳,進一步較佳為3~10mg。
鎂:以5~100mg為較佳,進一步較佳為10~80mg。
泛酸:以50~400mg為較佳,進一步較佳為120~300mg。
生物素:以50~500μg為較佳,進一步較佳為150~450μg。
葉酸:以100~1,500μg為較佳,進一步較佳為450~1,200μg。
本發明之認知機能改善劑,調製為醫藥部外品或醫藥品時,
可將上述有效成分,與醫藥品中可容許之無毒性載體、稀釋劑或賦形劑,一同調製為錠劑(包含裸錠、糖衣錠、發泡錠、膜衣錠、咀嚼錠、口含錠等)、膠囊劑、丸劑、粉末劑(散劑)、細粒劑、顆粒劑、液劑、懸浮液、乳化液、糖漿、藥膏、注射劑(包含使用時,配合蒸餾水、胺基酸輸液、電解質輸液等調製為液劑之情形)等型態,作為醫藥用之製劑。
上述醫藥部外品或醫藥品之投予方式並無特別限定,例如,可藉由動脈投藥、靜脈投藥、口頰投藥、直腸投藥、腸道投藥、經皮投藥、口服投藥等而施行。
上述醫藥部外品或醫藥品之投予劑量,可因應患者之體重、年齡、性別、症狀等種種條件而適當決定,成人每1人的本發明之認知機能改善劑之各有效成分之投予量,並無特別限制,例如,可列舉上述者。
本發明之認知機能改善劑,藉由使用維生素A、維生素B群(B1、B2、B6及B12)、維生素C、維生素D、維生素E、鋅、鎂、泛酸、生物素及葉酸此10種成分之組合,得到認知機能(特別係對於pre-MCI、MCI及失智症之患者)改善效果。本發明雖不預期被任何理論限制,惟推測以此10種有效成分之補充可促進ATP產生,從而藉由腦內環境之改善而獲得該效果。
因此,本發明之認知機能改善劑,係以認知機能之改善為目的而被使用。在此,「認知機能」係意指失智症中觀察到有障礙之機能。「認知機能」,係可列舉記憶力、注意力、語言機能、於身體進行一連續動作之機能、通過五感把握周圍狀況之機能、執行機能、定向力等。「失智症」係指因後天性腦器官障礙,使一度正常發展之知能不可逆地降低的狀態。在
此,「改善」亦包含症狀進一步惡化之防止,亦即維持。
本發明之認知機能改善劑之適用對象,係可列舉失智症(特別係阿茲海默症)之患者、MCI之患者、pre-MCI之患者等,惟適用對象亦包含以認知機能之維持為目的,而認知機能並無問題之高齡者。此外,本發明之認知機能改善劑,係適用於包含人類之哺乳動物。
本發明之認知機能改善劑,雖單獨使用之效果亦可期許,惟藉由與抗失智症治療藥(多耐派齊(Donepezil)、美金剛胺(memantine)、加蘭他敏(galantamine)、及利巴斯狄明(rivastigmine))之併用,可期許有效地延遲失智症之進行,及認知機能之改善。進一步地,本發明之認知機能改善劑,對維持MCI及失智症患者之ADL(日常生活活動)亦可期許。
以下,為了進一步詳細說明本發明而列舉實施例。然而,本發明係不限定於此等實施例。
試驗例
以10症例進行關於本發明之認知機能改善劑之試驗。試驗例10例中,7症例係為主觀健忘及易疲勞性之Pre-MCI患者,且3症例(No2、No3、No10)有主觀健忘及易疲勞性症狀,並在MMSE*1檢查及影像診斷上亦被診斷為Pre-MCI、MCI或失智症。在獲得投予大量維生素之同意之上,係對此10病例投予所定之維生素量而觀察其進程。具體而言,係投予受試者下述表1所示組成之膠囊劑。
*1MMSE檢查,係指作為失智症之篩檢測驗而於世界廣泛使用者,
由11個問題項目組成,若全部問題正解則得30分。
本試驗中,各受試者係在膠囊劑之投予前,及一定期間之投予後,接受醫師的診斷或面談。
所得結果係如表2所示。
MMSE及影像檢查中被診斷為Pre-MCI、MCI或失智症的3症例,原本係為須服用愛憶欣8-10mg、利憶靈16-24mg、美憶15-20mg程度之症例。然而,藉由使用本發明之認知機能改善劑,可停留於現行之藥物使用量。此外,除了認知機能,大部分的症例在表情之豐富度、身體敏捷性、疲勞、意志力等有所改善,因此可認為有腦血液循環之顯著改善。
其他7位健全者,在其他維生素下雖無格外之改善,在本劑下亦有特別明顯的認知機能改善、疲勞恢復、眼睛疲勞恢復。
Claims (5)
- 一種認知機能改善劑,其係以維生素A、維生素B群(B1、B2、B6及B12)、維生素C、維生素D、維生素E、鋅、鎂、泛酸、生物素及葉酸作為有效成分。
- 如申請專利範圍第1項所記載之認知機能改善劑,其中,維生素D之含有量係為0.0008質量%以上。
- 如申請專利範圍第1或2項所記載之認知機能改善劑,其中,維生素A之含有量係為0.085質量%以下。
- 如申請專利範圍第1至3項所記載之認知機能改善劑,其中,鋅之含有量係為0.35質量%以下。
- 一種改善認知機能之方法,其係包含將維生素A、維生素B群(B1、B2、B6及B12)、維生素C、維生素D、維生素E、鋅、鎂、泛酸、生物素及葉酸投予哺乳動物之步驟。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016081881 | 2016-04-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201737904A true TW201737904A (zh) | 2017-11-01 |
Family
ID=60041648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW106112422A TW201737904A (zh) | 2016-04-15 | 2017-04-13 | 認知機能改善劑 |
Country Status (6)
Country | Link |
---|---|
US (1) | US10695369B2 (zh) |
EP (1) | EP3443965A4 (zh) |
JP (1) | JP6923940B2 (zh) |
CN (1) | CN109069534B (zh) |
TW (1) | TW201737904A (zh) |
WO (1) | WO2017179644A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102275981B1 (ko) * | 2020-03-31 | 2021-07-13 | 고려은단주식회사 | 섬쑥부쟁이 추출물과 비타민 b 복합체의 혼합물을 포함하는 인지기능 개선용 조성물 |
EP3981407A1 (de) | 2020-10-07 | 2022-04-13 | WÖRWAG Pharma GmbH & Co.KG | Biofaktoren zur behandlung und prophylaxe von demenz |
KR102582570B1 (ko) | 2021-03-19 | 2023-09-22 | 한국생명공학연구원 | 유박테리움 칼란데리, 이의 배양액 또는 이의 배양액 추출물을 유효성분으로 포함하는 암 예방 또는 치료용 조성물 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE428312T1 (de) | 2004-01-29 | 2009-05-15 | Indena Spa | Verwendung von ginkgokomplexen zur verbesserung von kognitiven leistungen und linderung der mentalen ermüdung |
US9579298B2 (en) * | 2004-12-02 | 2017-02-28 | Piotr Chomczynski | Antioxidant dietary supplement compositions and methods for maintaining healthy skin |
EP2001293B9 (en) * | 2006-04-03 | 2019-04-17 | Accera, Inc. | Use of ketogenic compounds for treatment of age-associated memory impairment |
US20090196862A1 (en) * | 2008-01-22 | 2009-08-06 | William Davis | High dosage Vitamin D |
RU2428062C2 (ru) * | 2009-10-09 | 2011-09-10 | ЗАО "Академия-Т" | Композиция для функционального напитка |
US8962042B2 (en) * | 2010-09-28 | 2015-02-24 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
WO2013066151A1 (en) * | 2011-10-31 | 2013-05-10 | N.V. Nutricia | Improving recognition |
DE202014102551U1 (de) * | 2014-05-30 | 2015-02-26 | Orthomol Pharmazeutische Vertriebs Gmbh | Diätetische Zubereitung in Form eines Riegels |
-
2017
- 2017-04-13 US US16/090,843 patent/US10695369B2/en active Active
- 2017-04-13 JP JP2018512057A patent/JP6923940B2/ja active Active
- 2017-04-13 WO PCT/JP2017/015084 patent/WO2017179644A1/ja active Application Filing
- 2017-04-13 EP EP17782457.0A patent/EP3443965A4/en not_active Withdrawn
- 2017-04-13 TW TW106112422A patent/TW201737904A/zh unknown
- 2017-04-13 CN CN201780023085.7A patent/CN109069534B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
JPWO2017179644A1 (ja) | 2019-02-21 |
EP3443965A1 (en) | 2019-02-20 |
US10695369B2 (en) | 2020-06-30 |
CN109069534A (zh) | 2018-12-21 |
WO2017179644A1 (ja) | 2017-10-19 |
EP3443965A4 (en) | 2020-02-19 |
CN109069534B (zh) | 2021-04-20 |
JP6923940B2 (ja) | 2021-08-25 |
US20190117687A1 (en) | 2019-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Balch | Prescription for nutritional healing | |
US7932288B2 (en) | Composition for relieving subjective symptoms of fatigue | |
CN104822279A (zh) | 缓减压力症状的人乳寡糖 | |
AU2013340318B2 (en) | Use of tryptophan rich protein hydrolysates | |
CN109069534B (zh) | 认知功能改善剂 | |
JP6991092B2 (ja) | 睡眠の質改善剤 | |
CA2868017A1 (en) | Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance | |
JP2009292798A (ja) | 認知症を処置するための組成物及びその利用 | |
WO2005087022A1 (ja) | 抗ストレス作用を有する食品組成物 | |
JP6879297B2 (ja) | 加齢に伴う身体機能低下もしくは身体機能障害、または加齢に伴う精神機能低下もしくは精神機能障害の抑制または改善用組成物 | |
JP2022116116A (ja) | 飲食品組成物 | |
JPH0549444A (ja) | 耐久力増強用食品 | |
US20150238447A1 (en) | Beta-hydroxy-beta-methylbutryic acid-containing compositions and uses thereof | |
JP6650852B2 (ja) | ドコサヘキサエン酸を含有する睡眠の質改善剤 | |
JP2009254242A (ja) | 砂糖様味質をもつ新規甘味料、その製造法および用途 | |
CA2459240C (en) | Pharmaceutical composition for treating mood disorders | |
KR101697260B1 (ko) | 보글리보즈를 유효성분으로 함유하는 비만 개선, 정장 또는 장내 균총 개선용 조성물 | |
US20230124668A1 (en) | Psychological fatigue preventer or improver | |
JP7430172B2 (ja) | 腸内菌叢中のフィーカリバクテリウム属菌の占有率を増加させるための組成物 | |
CN111511372A (zh) | 预防或减轻非酒精性脂肪肝疾病的组合物 | |
US20230050805A1 (en) | Autonomic nerve regulator and cognitive function improver | |
TW201808120A (zh) | 行動體力提升劑 | |
JP2023033782A (ja) | 疲労及び/又は気分状態改善用組成物 | |
JP2007119348A (ja) | 冷え症改善剤 | |
WO2019172369A1 (ja) | 出血性血管障害の予防または抑制のための組成物 |